Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

ItalyBack to Italy

Clinical trials in Sassari – page 5

54 clinical trials in Sassari, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Sassari at a glance
54
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

54 trials in Sassari

Open in trial search

Asthma

Not recruiting

Study Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma

Registered drug
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:Glaxosmithkline Research & Development Limited

Chronic myeloid leukaemia

Not recruiting

Comparison of nilotinib versus imatinib treatment in newly diagnosed chronic myeloid leukemia patients to achieve treatment-free remission

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Imatinib
  • Sponsor:Fondazione Gimema Franco Mandelli Onlus

HIV infection

Not recruiting

Study Comparing Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Treatment in Adults New to Antiretroviral Therapy

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bictegravir
  • Sponsor:Viiv Healthcare UK Limited

Open angle glaucoma+2

Not recruiting

Study on the Effectiveness of Citicoline Eye Drops for Visual Field Preservation in Patients with Open Angle Glaucoma

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Citicoline Sodium
  • Sponsor:Omikron Italia S.r.l.

Acute coronary syndrome

Not recruiting

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Neuroendocrine carcinoma metastatic

Not recruiting

Study of durvalumab, carboplatin and etoposide combination therapy for patients with metastatic large-cell neuroendocrine lung cancer who have not received previous treatment

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:GOIRC Gruppo Oncologico Italiano Di Ricerca Clinica

Other cities in Italy

The busiest research cities in the country

All 237 cities in Italy

Clinical research in Sassari

What the registry says about research in the country

01 Oncology Research

Groundbreaking studies focusing on colorectal cancer, breast cancer, and lung cancer treatments. Multiple trials are evaluating novel therapeutic approaches including immunotherapy combinations and targeted treatments.

  • Metastatic colorectal cancer treatments
  • Early-stage breast cancer therapies
  • Advanced NSCLC treatments

Advanced research includes studies on precision medicine approaches and combination therapies.

02 Respiratory Medicine

Innovative clinical trials examining treatments for chronic respiratory conditions, including studies on severe asthma and COPD management approaches.

  • COPD exacerbation prevention
  • Severe asthma treatments
  • Pulmonary fibrosis therapies

Research focuses on improving patient outcomes through targeted biological therapies.

03 Infectious Diseases

Comprehensive research programs investigating treatments for HIV and Hepatitis B, with emphasis on innovative therapeutic strategies and drug combinations.

  • HIV treatment optimization
  • Hepatitis B management
  • Antiviral therapies

Studies aim to improve treatment efficacy and patient quality of life.

Back to ItalyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.